Understanding Pancreatic Cancer Prognosis
Mutations in four main genes influence survival rates of pancreatic adenocarcinoma patients
Roisin McGuigan |
Despite increased research efforts in recent years, survival rates for pancreatic cancer remain relatively low, with only 3.3 percent of adults surviving for five years with the disease (1), and researchers around the globe are working hard on new directions to aid in diagnosis, prognosis and treatment.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.